A 'More Radical Idea': Set Expiration Dates For Priority Review Vouchers
Executive Summary
Sanofi executive offers five-year voucher life-span as potential option for sustaining the resale market.
You may also be interested in...
Rare Pediatric Disease Voucher Program Gains Temporary Extension From House Committee
US incentive program would gain only four more years, despite calls for a permanent extension.
Priority Review Vouchers Post Lower Average Approval Times Than Priority NMEs
US FDA’s priority review voucher program delivers for most sponsors, a Pink Sheet analysis finds; PRVs reliably produce faster approval than priority-reviewed new drugs overall.
US FDA Priority Review Voucher Fee Continues Drop In FY 2020
Sponsors will pay 12% less to redeem a voucher in FY 2020, which is charged on top of the traditional PDUFA user fee.